Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹192 Cr₹95 Cr₹155 Cr₹179 Cr₹174 Cr

What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES is ₹192 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹192 Cr
Mar2025₹95 Cr
Mar2024₹155 Cr
Mar2023₹179 Cr
Mar2022₹174 Cr

How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹192 Cr
102.48
Mar2025 ₹95 Cr
-38.90
Mar2024 ₹155 Cr
-13.11
Mar2023 ₹179 Cr
2.88
Mar2022 ₹174 Cr -

Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,030.1 Cr 2.5% -4% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.5%

-4%

-17%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses